HIV Vaccines

Although there isn't currently an AIDS antibody, efforts to develop an immunization against HIV, the infection that causes AIDS, have been ongoing for a very long time. A HIV antibody may be effective in either of two ways. A "preventive" immunization would prevent HIV contamination from occurring entirely, whereas a "remedial" antibody would not prevent sickness but would treat or delay illness in people who become contaminated and may also reduce the risk of them spreading the infection to others. Even though a protective antibody would be ideal, beneficial vaccines would also be incredibly beneficial. The main goal of all HIV vaccinations is to strengthen the immune system of humans so they can fight HIV.

  • BNT162b2/COMIRNATY Tozinameran (INN)-BioNTech Manufacturing GmbH
  •   AZD1222 Vaxzervria --AstraZeneca, AB

    Related Conference of HIV Vaccines

    May 30-31, 2024

    World congress on Immunology and Virology Diseases

    Vienna, Austria
    August 01-02, 2024

    44th Global Summit and Expo on Vaccines & Immunology

    Montreal, Canada
    September 09-10, 2024

    4th International Conference on Vaccine Research

    Madrid, Spain
    November 28-29, 2024

    6th World Congress on Vaccine and Immunology

    Paris, France

    HIV Vaccines Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in